Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Angus W. Thomson
Angus W. Thomson PhD, DSc, DSc(Med), FAST is a Distinguished Professor of Surgery and Immunology and Professor of Clinical and Translational Science at the Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. His principal research interests are in mechanisms underlying tolerance induction and in the evaluation of innovative strategies to promote organ transplant tolerance. Dr Thomson has received numerous National Institutes of Health project and program grants for his studies on the immune regulatory roles and therapeutic applications of dendritic cells and T cells in transplantation. He has published over 450 peer-reviewed scientific articles and edited several advanced text books, including texts on cytokine and dendritic cell biology.
Dr Gerald Brandacher is Scientific Director of the Johns Hopkins Reconstructive Transplantation program. He is also an Associate Professor of Surgery in the Departments of Surgery and Plastic and Reconstructive Surgery at Johns Hopkins University School of Medicine, Maryland, USA. Prior to joining Johns Hopkins in 2010, Dr Brandacher was a key member of the hand transplant programs in Innsbruck, Austria and at the University of Pittsburgh, Pennsylvania, USA. As Scientific Director of the program at UPMC, he was instrumental in designing a novel cell-based immunomodulatory treatment protocol for VCA and was also part of the team performing the first bilateral hand transplant and first forearm transplant in the USA. His main scientific interests are donor-specific immune tolerance and immunomonitoring strategies. Dr Brandacher received his medical degree summa cum laude from Leopold Franzens University, Innsbruck, School of Medicine, and completed further surgical training at the Center of Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery, at Innsbruck Medical University. He is the recipient of many prestigious national and international awards related to his work in reconstructive transplantation including The Young Investigator Awards of the American Society of Transplantation and the European Society of Organ Transplantation, The Young Innovator Award of the American Society of Transplantation and the Excellence in Research Award of the American College of Surgeons. Dr Brandacher has mentored 60 pre and post-doctoral researches over the past 15 years, and has authored more than 195 peer reviewed papers, 27 book chapters, and has edited two textbooks on hand transplantation. In 2014, he co-founded the journal Vascularized Composite Allotransplantation (VCA), and currently serves as its Editor-in-Chief. Dr Brandacher is the principal investigator of multiple major federal research grants totaling >10 M USD in funding on projects related to upper extremity transplantation, cell-based immune modulation, and tolerance induction. He has given over 130 invited lectures and has been a visiting professor around the world and at leading American medical institutions. Dr Brandacher has served as the President of the Austrian Society of Surgical Research (2008–2009) and as Chair of the American Society of Transplantation (AST) Vascular Composite Allotransplantation Advisory Council (2014–15). He was elected as Chair of the Vascularized Composite Allotransplantation Committee of the European Society of Organ Transplantation (ESOT) in 2015, and is a Founding Member of the American Society of Reconstructive Transplantation (ASRT), for which he currently serves as the President Elect. He is a Member at Large to the OPTN/UNOS Vascularized Composite Allograft Transplantation (VCA) Committee. In 2015, he was selected as a “Fellow of the American Society of Transplantation”.